These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Triplex formation on DNA targets: how to choose the oligonucleotide. Vekhoff P; Ceccaldi A; Polverari D; Pylouster J; Pisano C; Arimondo PB Biochemistry; 2008 Nov; 47(47):12277-89. PubMed ID: 18954091 [TBL] [Abstract][Full Text] [Related]
23. Triple helix formation on plasmid DNA determined by a size-exclusion chromatographic method. Escriou V; Lagneaux D; Crouzet J; Wils P; Scherman D Anal Biochem; 1997 May; 248(1):102-10. PubMed ID: 9177729 [TBL] [Abstract][Full Text] [Related]
24. Combining nucleoside analogues to achieve recognition of oligopurine tracts by triplex-forming oligonucleotides at physiological pH. Rusling DA; Le Strat L; Powers VE; Broughton-Head VJ; Booth J; Lack O; Brown T; Fox KR FEBS Lett; 2005 Dec; 579(29):6616-20. PubMed ID: 16293248 [TBL] [Abstract][Full Text] [Related]
25. Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the rat alpha 1(I) collagen promoter specifically inhibits factor binding and transcription. Kovacs A; Kandala JC; Weber KT; Guntaka RV J Biol Chem; 1996 Jan; 271(3):1805-12. PubMed ID: 8576186 [TBL] [Abstract][Full Text] [Related]
26. Triple helix formation with oligodeoxyribonucleotides containing 8-oxo-2'-deoxyadenosine and 2'-modified nucleoside derivatives. Ishibashi T; Yamakawa H; Wang Q; Tsukahara S; Takai K; Maruyama T; Takaku H Nucleic Acids Symp Ser; 1995; (34):127-8. PubMed ID: 8841585 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and alternate-stranded triple helix forming ability of novel anthraquinone modified alpha-beta chimeric DNA. Moriguchi T; Azam AT; Shinozuka K Nucleic Acids Symp Ser (Oxf); 2005; (49):7-8. PubMed ID: 17150606 [TBL] [Abstract][Full Text] [Related]
28. Characterization and quantification of triple helix formation in chromosomal DNA. Besch R; Giovannangeli C; Schuh T; Kammerbauer C; Degitz K J Mol Biol; 2004 Aug; 341(4):979-89. PubMed ID: 15328613 [TBL] [Abstract][Full Text] [Related]
29. Benzoquinoquinoxaline derivatives stabilize and cleave H-DNA and repress transcription downstream of a triplex-forming sequence. Amiri H; Nekhotiaeva N; Sun JS; Nguyen CH; Grierson DS; Good L; Zain R J Mol Biol; 2005 Aug; 351(4):776-83. PubMed ID: 16045927 [TBL] [Abstract][Full Text] [Related]
30. Selective DNA cleavage by metalloporphyrin derivatives. Pratviel G; Bernadou J; Meunier B Met Ions Biol Syst; 1996; 33():399-426. PubMed ID: 8742850 [No Abstract] [Full Text] [Related]
31. Structure/nuclease activity relationships of DNA cleavers based on cationic metalloporphyrin-oligonucleotide conjugates. Mestre B; Jakobs A; Pratviel G; Meunier B Biochemistry; 1996 Jul; 35(28):9140-9. PubMed ID: 8703919 [TBL] [Abstract][Full Text] [Related]
32. Supramolecular helical porphyrin arrays using DNA as a scaffold. Bouamaied I; Nguyen T; Rühl T; Stulz E Org Biomol Chem; 2008 Nov; 6(21):3888-91. PubMed ID: 18931790 [TBL] [Abstract][Full Text] [Related]
33. Targeted genome modification via triple helix formation. Kalish JM; Glazer PM Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134 [TBL] [Abstract][Full Text] [Related]
34. Preparation and nuclease activity of hybrid "metallotris(methylpyridinium)porphyrin oligonucleotide" molecules having a 3'-loop for protection against 3'-exonucleases. Mestre B; Pratviel G; Meunier B Bioconjug Chem; 1995; 6(4):466-72. PubMed ID: 7578367 [TBL] [Abstract][Full Text] [Related]
35. Design of manganese porphyrin modified with mitochondrial signal peptide for a new antioxidant. Asayama S; Kawamura E; Nagaoka S; Kawakami H Mol Pharm; 2006; 3(4):468-70. PubMed ID: 16889441 [TBL] [Abstract][Full Text] [Related]
36. Alternate-strand DNA triple-helix formation using short acridine-linked oligonucleotides. Washbrook E; Fox KR Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):569-75. PubMed ID: 8043005 [TBL] [Abstract][Full Text] [Related]
37. Facilitation of the cellular uptake of a triplex-forming oligonucleotide by novel polyamine analogues: structure-activity relationships. Thomas RM; Thomas T; Wada M; Sigal LH; Shirahata A; Thomas TJ Biochemistry; 1999 Oct; 38(40):13328-37. PubMed ID: 10529208 [TBL] [Abstract][Full Text] [Related]
38. Sequence-specific gene cleavage in intact mammalian cells by 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide. Sedelnikova OA; Karamychev VN; Panyutin IG; Neumann RD Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):43-9. PubMed ID: 12022689 [TBL] [Abstract][Full Text] [Related]
39. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603 [TBL] [Abstract][Full Text] [Related]
40. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment. Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]